ArticleBMC cancer2022

Correction: Aberrant hydroxymethylation in promoter CpG regions of genes related to the cell cycle and apoptosis characterizes advanced chronic myeloid leukemia disease, poor imatinib respondents and poor survival.

Sameer Ahmad Guru et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.